EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER

The problem of treatment of oncological diseases is one of the most urgent for modern medicine. Existing treatment approaches are based on a surgical, radiation, chemotherapeutic approach, and the use of immunotherapy methods aimed at markers and / or specific antigens of tumors.Approaches based on...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	V. V. Kurilin, E. V. Kulikova, A. V. Sokolov, Yu. A. Kozhevnikov, D. D. Blinova, I. A. Obleukhova, N. M. Starostina, S. V. Sennikov
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2021
Materias:	immunotherapy dendritic cells tumor antigens cellular cytotoxicity colorectal cancer Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/08fa2a7c4136433aa1b43a7301e7807f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:08fa2a7c4136433aa1b43a7301e7807f
record_format	dspace
spelling	oai:doaj.org-article:08fa2a7c4136433aa1b43a7301e7807f2021-11-18T08:03:51ZEFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER1563-06252313-741X10.15789/1563-0625-EOA-2251https://doaj.org/article/08fa2a7c4136433aa1b43a7301e7807f2021-10-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/2251https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XThe problem of treatment of oncological diseases is one of the most urgent for modern medicine. Existing treatment approaches are based on a surgical, radiation, chemotherapeutic approach, and the use of immunotherapy methods aimed at markers and / or specific antigens of tumors.Approaches based on the mechanisms of cellular and molecular regulation of a specific antitumor immune response have shown their high efficiency (for example, antibodies against HER2 in breast cancer), but these approaches have a number of side and undesirable effects that limit their application. Considering the central role of the mechanisms of recognition of tumor antigens and their presentation to cytotoxic cells in effective tumor elimination, it is important to search for and develop approaches to restore these mechanisms in cancer pathology. Because maturation, differentiation of dendritic cells and their main function are impaired in oncological diseases, scientific research is underway to obtain mature dendritic cells and restore the natural way of antigen presentation to effector cells.The work carried out limited clinical studies (13 patients with colorectal cancer), a previously developed protocol for obtaining antigen-primed dendritic cells of patients with colorectal cancer and their joint culture with autologous mononuclear cells in vitro. From the peripheral blood of cancer patients, dendritic cells primed with autologous tumor antigens (tumor cell lysate), which were co-cultured with their own mononuclear cells in the presence of immunoregulatory cytokines (IL-12 and IL-18). The resulting cell suspensions were purified from the culture medium and cytokines and used for a course of immunotherapy (weekly, 20-30 million cells intravenously, dropwise), consisting of 3-5 injections. At different periods of immunotherapy (before the start of the course of immunotherapy, 3 months and 6 months after the end of immunotherapy), immunological parameters were assessed in the peripheral blood of patients (immunogram (CD3+, CD3+CD4+, CD3+CD8+, CD19, CD16+CD56+-cells), the relative content of T-regulatory cells (CD4+CD25+FoxP3+-cells), myeloid suppressor cells (CD14+HLA-DR- cells)) and assessed the cytotoxic activity of peripheral blood mononuclear cells of patients against cells of the tumor line of human colorectal cancer (Colo-320).The data obtained showed that in cancer patients, against the background of ongoing immunotherapy, the indicator of the direct cytotoxic test significantly increases, which makes it possible to judge the effective stimulation of the antitumor cellular immune response. This is also indicated by an increase in the relative number of CD16+CD56+-cells (NK-cells) 3 months after immunotherapy. The study of immunosuppressive cells in the blood of cancer patients showed the absence of significant changes in CD14+HLA-DR- -cells and T-regulatory cells.Thus, limited clinical studies of immunotherapy of patients with colorectal cancer based on autologous dendritic cells primed with lysate of autologous tumor cells demonstrated an increase in the antitumor cytotoxic immune response.V. V. KurilinE. V. KulikovaA. V. SokolovYu. A. KozhevnikovD. D. BlinovaI. A. ObleukhovaN. M. StarostinaS. V. SennikovSPb RAACIarticleimmunotherapydendritic cellstumor antigenscellular cytotoxicitycolorectal cancerImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 23, Iss 4, Pp 963-968 (2021)
institution	DOAJ
collection	DOAJ
language	RU
topic	immunotherapy dendritic cells tumor antigens cellular cytotoxicity colorectal cancer Immunologic diseases. Allergy RC581-607
spellingShingle	immunotherapy dendritic cells tumor antigens cellular cytotoxicity colorectal cancer Immunologic diseases. Allergy RC581-607 V. V. Kurilin E. V. Kulikova A. V. Sokolov Yu. A. Kozhevnikov D. D. Blinova I. A. Obleukhova N. M. Starostina S. V. Sennikov EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
description	The problem of treatment of oncological diseases is one of the most urgent for modern medicine. Existing treatment approaches are based on a surgical, radiation, chemotherapeutic approach, and the use of immunotherapy methods aimed at markers and / or specific antigens of tumors.Approaches based on the mechanisms of cellular and molecular regulation of a specific antitumor immune response have shown their high efficiency (for example, antibodies against HER2 in breast cancer), but these approaches have a number of side and undesirable effects that limit their application. Considering the central role of the mechanisms of recognition of tumor antigens and their presentation to cytotoxic cells in effective tumor elimination, it is important to search for and develop approaches to restore these mechanisms in cancer pathology. Because maturation, differentiation of dendritic cells and their main function are impaired in oncological diseases, scientific research is underway to obtain mature dendritic cells and restore the natural way of antigen presentation to effector cells.The work carried out limited clinical studies (13 patients with colorectal cancer), a previously developed protocol for obtaining antigen-primed dendritic cells of patients with colorectal cancer and their joint culture with autologous mononuclear cells in vitro. From the peripheral blood of cancer patients, dendritic cells primed with autologous tumor antigens (tumor cell lysate), which were co-cultured with their own mononuclear cells in the presence of immunoregulatory cytokines (IL-12 and IL-18). The resulting cell suspensions were purified from the culture medium and cytokines and used for a course of immunotherapy (weekly, 20-30 million cells intravenously, dropwise), consisting of 3-5 injections. At different periods of immunotherapy (before the start of the course of immunotherapy, 3 months and 6 months after the end of immunotherapy), immunological parameters were assessed in the peripheral blood of patients (immunogram (CD3+, CD3+CD4+, CD3+CD8+, CD19, CD16+CD56+-cells), the relative content of T-regulatory cells (CD4+CD25+FoxP3+-cells), myeloid suppressor cells (CD14+HLA-DR- cells)) and assessed the cytotoxic activity of peripheral blood mononuclear cells of patients against cells of the tumor line of human colorectal cancer (Colo-320).The data obtained showed that in cancer patients, against the background of ongoing immunotherapy, the indicator of the direct cytotoxic test significantly increases, which makes it possible to judge the effective stimulation of the antitumor cellular immune response. This is also indicated by an increase in the relative number of CD16+CD56+-cells (NK-cells) 3 months after immunotherapy. The study of immunosuppressive cells in the blood of cancer patients showed the absence of significant changes in CD14+HLA-DR- -cells and T-regulatory cells.Thus, limited clinical studies of immunotherapy of patients with colorectal cancer based on autologous dendritic cells primed with lysate of autologous tumor cells demonstrated an increase in the antitumor cytotoxic immune response.
format	article
author	V. V. Kurilin E. V. Kulikova A. V. Sokolov Yu. A. Kozhevnikov D. D. Blinova I. A. Obleukhova N. M. Starostina S. V. Sennikov
author_facet	V. V. Kurilin E. V. Kulikova A. V. Sokolov Yu. A. Kozhevnikov D. D. Blinova I. A. Obleukhova N. M. Starostina S. V. Sennikov
author_sort	V. V. Kurilin
title	EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
title_short	EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
title_full	EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
title_fullStr	EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
title_full_unstemmed	EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
title_sort	effect of antigen-primed dendritic cell-based immunotherapy on antitumor cellular immune response in patients with colorectal cancer
publisher	SPb RAACI
publishDate	2021
url	https://doaj.org/article/08fa2a7c4136433aa1b43a7301e7807f
work_keys_str_mv	AT vvkurilin effectofantigenprimeddendriticcellbasedimmunotherapyonantitumorcellularimmuneresponseinpatientswithcolorectalcancer AT evkulikova effectofantigenprimeddendriticcellbasedimmunotherapyonantitumorcellularimmuneresponseinpatientswithcolorectalcancer AT avsokolov effectofantigenprimeddendriticcellbasedimmunotherapyonantitumorcellularimmuneresponseinpatientswithcolorectalcancer AT yuakozhevnikov effectofantigenprimeddendriticcellbasedimmunotherapyonantitumorcellularimmuneresponseinpatientswithcolorectalcancer AT ddblinova effectofantigenprimeddendriticcellbasedimmunotherapyonantitumorcellularimmuneresponseinpatientswithcolorectalcancer AT iaobleukhova effectofantigenprimeddendriticcellbasedimmunotherapyonantitumorcellularimmuneresponseinpatientswithcolorectalcancer AT nmstarostina effectofantigenprimeddendriticcellbasedimmunotherapyonantitumorcellularimmuneresponseinpatientswithcolorectalcancer AT svsennikov effectofantigenprimeddendriticcellbasedimmunotherapyonantitumorcellularimmuneresponseinpatientswithcolorectalcancer
_version_	1718422270321360896

EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER

Ejemplares similares